The impact of viral respiratory infection on the severity and recovery from an asthma exacerbation
- PMID: 19258918
- DOI: 10.1097/INF.0b013e31819067b1
The impact of viral respiratory infection on the severity and recovery from an asthma exacerbation
Abstract
Background: : Viral respiratory illness triggers asthma exacerbations, but the influence of respiratory illness on the acute severity and recovery of childhood asthma is unknown. Our objective was to evaluate the impact of a concurrent acute respiratory illness (based on a clinical definition and PCR detection of a panel of respiratory viruses, Mycoplasma pneumoniae and Chlamydia pneumoniae) on the severity and resolution of symptoms in children with a nonhospitalized exacerbation of asthma.
Methods: : Subjects were children aged 2 to 15 years presenting to an emergency department for an acute asthma exacerbation and not hospitalized. Acute respiratory illness (ARI) was clinically defined. Nasopharyngeal aspirates (NPA) were examined for respiratory viruses, Chlamydia and Mycoplasma using PCR. The primary outcome was quality of life (QOL) on presentation, day 7 and day 14. Secondary outcomes were acute asthma severity score, asthma diary, and cough diary scores on days 5, 7, 10, and 14.
Results: : On multivariate regression, presence of ARI was statistically but not clinically significantly associated with QOL score on presentation (B = -0.36, P = 0.025). By day 7 and 14, there was no difference between groups. Asthma diary score was significantly higher in children with ARI (B = 0.41, P = 0.039) on day 5 but not on presentation or subsequent days. Respiratory viruses were detected in 54% of the 78 NPAs obtained. There was no difference in the any of the asthma outcomes of children grouped by positive or negative NPA.
Conclusions: : The presence of a viral respiratory illness has a modest influence on asthma severity, and does not influence recovery from a nonhospitalized asthma exacerbation.
Similar articles
-
Presence of atopy increases the risk of asthma relapse.Arch Dis Child. 2018 Apr;103(4):346-351. doi: 10.1136/archdischild-2017-312982. Epub 2017 Oct 11. Arch Dis Child. 2018. PMID: 29021189
-
Contribution of viruses, Chlamydia spp. and Mycoplasma pneumoniae to acute respiratory infections in Iranian children.J Trop Pediatr. 2007 Jun;53(3):179-84. doi: 10.1093/tropej/fml089. Epub 2007 Feb 7. J Trop Pediatr. 2007. PMID: 17287243 Clinical Trial.
-
Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children.J Clin Virol. 1999 Aug;13(3):131-9. doi: 10.1016/s1386-6532(99)00030-x. J Clin Virol. 1999. PMID: 10443789 Free PMC article.
-
Infections and asthma.Clin Chest Med. 2006 Mar;27(1):87-98, vi. doi: 10.1016/j.ccm.2005.10.004. Clin Chest Med. 2006. PMID: 16543054 Review.
-
Viral respiratory infection and the link to asthma.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S78-86. doi: 10.1097/01.inf.0000108196.46134.a6. Pediatr Infect Dis J. 2004. PMID: 14730274 Review.
Cited by
-
Respiratory Viruses and Asthma.Semin Respir Crit Care Med. 2018 Feb;39(1):45-55. doi: 10.1055/s-0037-1617412. Epub 2018 Feb 10. Semin Respir Crit Care Med. 2018. PMID: 29427985 Free PMC article. Review.
-
The Identification and Clinical Value Evaluation of CYCS Related to Asthma through Bioinformatics Analysis and Functional Experiments.Dis Markers. 2023 Apr 14;2023:5746940. doi: 10.1155/2023/5746940. eCollection 2023. Dis Markers. 2023. Retraction in: Dis Markers. 2023 Dec 13;2023:9814817. doi: 10.1155/2023/9814817. PMID: 37091894 Free PMC article. Retracted.
-
Exacerbation of asthma and airway infection: is the virus the villain?J Pediatr (Rio J). 2014 Nov-Dec;90(6):542-55. doi: 10.1016/j.jped.2014.07.001. Epub 2014 Sep 26. J Pediatr (Rio J). 2014. PMID: 25261603 Free PMC article. Review.
-
Improving the Diagnosis, Management, and Outcomes of Children with Pneumonia: Where are the Gaps?Front Pediatr. 2013 Oct 23;1:29. doi: 10.3389/fped.2013.00029. Front Pediatr. 2013. PMID: 24400275 Free PMC article. Review.
-
Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol.Trials. 2011 Apr 14;12:94. doi: 10.1186/1745-6215-12-94. Trials. 2011. PMID: 21492416 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical